Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Blis MD vs Virta Health

Blis MD
Graded #74

Higher grade

vs+13
Virta Health
Graded #336

Lower grade

The verdict

Blis MD takes it — 72.7/100 to 59.7/100.

Blis MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Blis MD is a US telehealth offering personalized GLP-1 weight-loss treatment with compounded semaglutide and tirzepatide, prescribed after a free virtual consultation with a licensed provider.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBlis MD +43
88
45
Dose & formulationBlis MD +21
72
51
Clinical oversightVirta Health +3
74
77
Labs & monitoringVirta Health +9
62
71
FulfillmentEven
65
65
Contract termsEven
55
55
Blis MD · left barVirta Health · right bar

The numbers

MetricBlis MDVirta Health
WeighScore72.7/10059.7/100
GradeCC
Scorecard rank#74#336
Semaglutide$139/moNot disclosed
Tirzepatide$199/moNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Blis MD

Graded #74 · C

Strengths

  • Transparent flat monthly pricing published upfront (139 dollars semaglutide, 199 dollars tirzepatide)
  • Free initial virtual consultation with a licensed provider
  • Both semaglutide and tirzepatide offered with ongoing provider check-ins

Where it loses points

  • Compounding pharmacy is not named publicly
  • States served are not listed on the site
  • Thin public trust signals (no LegitScript seal or named medical director found)
Virta Health

Graded #336 · C

Strengths

  • Offers a Responsible Prescribing track with optimized GLP-1 use
  • Clinically monitored medication off-ramp toward nutrition therapy
  • Nutrition-first model shown to rival GLP-1 weight loss (about 13% at 1 year)
  • Provided at no cost to members through employers and health plans
  • Strong evidence base for diabetes reversal and metabolic health

Where it loses points

  • Primarily a nutrition program; GLP-1s are a secondary track
  • Distributed via employers and health plans, no direct cash-pay
  • Deliberately discourages GLP-1 use for most members
  • GLP-1 access depends on the specific program the plan selects

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard